No Data
Theravance Biopharma to Participate in an Upcoming Investor Conference
Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at...
Strong Week for Theravance Biopharma (NASDAQ:TBPH) Shareholders Doesn't Alleviate Pain of Five-year Loss
Theravance Biopharma, Inc. (NASDAQ:TBPH) shareholders should be happy to see the share price up 13% in the last week. But don't envy holders -- looking back over 5 years the returns have been reall
Theravance Biopharma(TBPH.US) 10% Shareholder Buys US$13.12 Million in Common Stock
$Theravance Biopharma(TBPH.US)$ 10% Shareholder Samaha Eli purchased 1.5 million shares of common stock on May 1, 2024 at an average price of $8.75 for a total value of $13.12 million.Source: Announce
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
DUBLIN, April 29, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 1
Sector Update: Health Care Stocks Lower Friday Afternoon
Health care stocks were retreating Friday afternoon, with the NYSE Health Care Index falling 1.5% and the Health Care Select Sector SPDR Fund (XLV) dropping 1.6%. The iShares Biotechnology ETF (IBB) w
Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy
Theravance Biopharma (TBPH) shares climbed 8.3% in recent Friday trading after BTIG started its coverage with a buy rating and a price target of $21. Trading volume stood at more than 330,000 shares a